Home FDA Removes Clinical Hold on Study of Pancreatic Cancer Drug
 

Keywords :   


FDA Removes Clinical Hold on Study of Pancreatic Cancer Drug

2014-06-08 05:12:05| Biotech - Topix.net

The FDA has removed its clinical hold on patient enrollment and dosing of PEGPH20 in an ongoing phase II trial evaluating the investigational compound in patients with pancreatic cancer, permitting the study to resume under a revised protocol.

Tags: study hold drug cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
07.11NextGen Label Group welcomes new VP of sales
07.11Genetic Symposium focusing on female reproductive success
07.11UNL commits $5 million to better measure environmental impact of cattle
07.11US cuts interest rates as Trump election raises uncertainty
07.11The Lehigh Short Course Website is Now Open
07.11Carbon Trust Verifies Four BASF Intermediates
07.11Atlantic Tropical Weather Outlook
07.11Eastern North Pacific Tropical Weather Outlook
More »